Literature DB >> 7684498

The tumor suppressor p53 regulates its own transcription.

A Deffie1, H Wu, V Reinke, G Lozano.   

Abstract

The ability of p53 to suppress transformation correlates with its ability to activate transcription. To identify targets of p53 transactivation, we examined the p53 promoter itself. Northern (RNA) analysis and transient transfection experiments showed that p53 transcriptionally regulated itself. A functionally inactive mutant p53 could not regulate the p53 promoter. Deletion analysis of the p53 promoter delineated sequences between +22 and +67 as being critical for regulation. Electrophoretic mobility shift analysis and methylation interference pinpointed the p53 DNA responsive element. When oligomerized in front of a heterologous minimal promoter, this element was regulated by wild-type p53 and not by mutant p53. Point mutations in the DNA element that eliminated protein-DNA interactions also resulted in a nonresponsive p53 promoter. The DNA element in the p53 promoter responsive to p53 regulation is similar to the p53 consensus sequence. However, we have been unable to detect a direct interaction of p53 with its promoter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684498      PMCID: PMC359810          DOI: 10.1128/mcb.13.6.3415-3423.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Oncogenic forms of p53 inhibit p53-regulated gene expression.

Authors:  S E Kern; J A Pietenpol; S Thiagalingam; A Seymour; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

3.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

4.  A dimer of AraC protein contacts three adjacent major groove regions of the araI DNA site.

Authors:  W Hendrickson; R Schleif
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Deletion of 5'-coding sequences of the cellular p53 gene in mouse erythroleukemia: a novel mechanism of oncogene regulation.

Authors:  B Rovinski; D Munroe; J Peacock; M Mowat; A Bernstein; S Benchimol
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

6.  Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex.

Authors:  T H Tan; J Wallis; A J Levine
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

7.  Isolation of a collagenase cDNA clone and measurement of changing collagenase mRNA levels during induction in rabbit synovial fibroblasts.

Authors:  R H Gross; L A Sheldon; C F Fletcher; C E Brinckerhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

Review 8.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Analysis of the gene coding for the murine cellular tumour antigen p53.

Authors:  B Bienz; R Zakut-Houri; D Givol; M Oren
Journal:  EMBO J       Date:  1984-09       Impact factor: 11.598

View more
  33 in total

1.  Differential binding of NF1 transcription factor to P53 gene promoter and its depletion in human breast tumours.

Authors:  B K Nayak; B R Das
Journal:  Mol Biol Rep       Date:  1999-12       Impact factor: 2.316

2.  Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex.

Authors:  E Chu; S M Copur; J Ju; T M Chen; S Khleif; D M Voeller; N Mizunuma; M Patel; G F Maley; F Maley; C J Allegra
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.

Authors:  E E Furlong; T Rein; F Martin
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

Review 4.  Corticosteroids in the brain. Cellular and molecular actions.

Authors:  M Joëls; E Vreugdenhil
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

5.  Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53.

Authors:  Caroline J DeHart; David H Perlman; S J Flint
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

Review 6.  p53 regulation upon genotoxic stress: intricacies and complexities.

Authors:  Rajni Kumari; Saishruti Kohli; Sanjeev Das
Journal:  Mol Cell Oncol       Date:  2014-12-23

7.  Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene.

Authors:  J Zhao; F I Schmieg; D T Simmons; G R Molloy
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Human cytomegalovirus IE1-72 protein interacts with p53 and inhibits p53-dependent transactivation by a mechanism different from that of IE2-86 protein.

Authors:  Eung-Soo Hwang; Zhigang Zhang; Haobin Cai; David Y Huang; Shu-Mei Huong; Chang-Yong Cha; Eng-Shang Huang
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

9.  Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells.

Authors:  L Sauer; D Gitenay; C Vo; V T Baron
Journal:  Oncogene       Date:  2010-03-01       Impact factor: 9.867

10.  Modeling the role of p53 pulses in DNA damage- induced cell death decision.

Authors:  Tingzhe Sun; Chun Chen; Yuanyuan Wu; Shuai Zhang; Jun Cui; Pingping Shen
Journal:  BMC Bioinformatics       Date:  2009-06-22       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.